Local Headless boundary
Host applications integrate through bounded API/native contracts rather than adopting a second end-user product surface.
An independent technical brief prepared around the Matrix Conference 2026 review period. It presents the MEMM product boundary, the R1001 Headless evidence model and the questions that matter when Matrix communication becomes an embedded component of PVS, KIS, OEM or platform products. It does not state or imply that a talk has been accepted.
MEMM is not presented as another visible messenger application. It is an integration boundary that lets a primary product own its UX and process while communication/runtime concerns stay behind versioned contracts.
Host applications integrate through bounded API/native contracts rather than adopting a second end-user product surface.
R1001 reports 63/63 Messenger domains, 100% Breadth and 37/37 host/native product operations as source-local evidence—not complete TI-M conformance.
WebRTC media runtime, provider interoperability, TI infrastructure, release approval and operating responsibility remain separate boundaries.
Fixed responsibility-bounded domains in the R1001 source state.
Arithmetic coverage of that fixed denominator.
Separate product-operation denominator across the bounded integration surface.
Call domains evidenced separately; the host owns WebRTC media runtime.
The useful discussion is usually about responsibility and change boundaries rather than a feature checklist.
When is a local SDK/FFI boundary operationally preferable to adding another REST/WebSocket control service?
How should subscriptions, lifecycle, errors and release changes cross the host/runtime boundary without introducing polling islands?
How can an embedded runtime keep cryptographic state and diagnostics bounded while the host retains its own product data and process ownership?
How do fixed denominators and source-bound proof help technical buyers without implying certification or universal interoperability?
This contact path is independent of conference participation or proposal outcome. Share only organization, target system and technical scope by ordinary email. Do not send patient, health, key or access data.